Literature DB >> 12182896

Effects of long-term hormone replacement and of tibolone on choline acetyltransferase and acetylcholinesterase activities in the brains of ovariectomized, cynomologus monkeys.

R B Gibbs1, D Nelson, M S Anthony, T B Clarkson.   

Abstract

We examined long-term effects of low and high doses of tibolone, conjugated equine estrogens, and conjugated equine estrogens plus medroxyprogesterone acetate on choline acetyltransferase and acetylcholinesterase activities within different regions of the brain in cynomologus monkeys. All treatments were administered for 2 years. None of the treatments produced significant increases in either choline acetyltransferase or acetylcholinesterase in any of eight brain regions analyzed. In contrast, treatment with conjugated equine estrogens plus medroxyprogesterone acetate, but not conjugated equine estrogens alone, produced significant reductions in both choline acetyltransferase and acetylcholinesterase in the medial septum/diagonal band of Broca compared with untreated controls. Treatment with tibolone also resulted in significant reductions in both choline acetyltransferase and acetylcholinesterase in the medial septum/diagonal band of Broca, and this effect was dose-related. These findings are the first to report the effects of long-term therapies used by postmenopausal women on cholinergic measures in the primate brain. The findings are consistent with recent reports in rats, and suggest that any positive effects of long-term estrogen or hormone replacement therapy on cognitive processes are probably not due to significant effects on choline acetyltransferase or acetylcholinesterase activities. Copyright 2002 IBRO

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12182896     DOI: 10.1016/s0306-4522(02)00239-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  18 in total

Review 1.  Normal genetic variation, cognition, and aging.

Authors:  P M Greenwood; Raja Parasuraman
Journal:  Behav Cogn Neurosci Rev       Date:  2003-12

Review 2.  Progesterone and neuroprotection.

Authors:  Meharvan Singh; Chang Su
Journal:  Horm Behav       Date:  2012-06-23       Impact factor: 3.587

3.  Differential effects on visual and spatial recognition memory of a novel hormone therapy regimen of estrogen alone or combined with progesterone in older surgically menopausal monkeys.

Authors:  M L Voytko; C J Higgs; R Murray
Journal:  Neuroscience       Date:  2008-05-03       Impact factor: 3.590

4.  Effect of Ovarian Hormone Therapy on Cognition in the Aged Female Rhesus Macaque.

Authors:  Steven G Kohama; Lauren Renner; Noelle Landauer; Alison R Weiss; Henryk F Urbanski; Byung Park; Mary Lou Voytko; Martha Neuringer
Journal:  J Neurosci       Date:  2016-10-05       Impact factor: 6.167

Review 5.  Sex differences in cognitive impairment and Alzheimer's disease.

Authors:  Rena Li; Meharvan Singh
Journal:  Front Neuroendocrinol       Date:  2014-01-13       Impact factor: 8.606

Review 6.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

7.  Executive function and attention are preserved in older surgically menopausal monkeys receiving estrogen or estrogen plus progesterone.

Authors:  Mary Lou Voytko; Rhonda Murray; Casey J Higgs
Journal:  J Neurosci       Date:  2009-08-19       Impact factor: 6.167

Review 8.  Progesterone-induced neuroprotection: factors that may predict therapeutic efficacy.

Authors:  Meharvan Singh; Chang Su
Journal:  Brain Res       Date:  2013-01-20       Impact factor: 3.252

9.  Effects of two years of conjugated equine estrogens on cholinergic neurons in young and middle-aged ovariectomized monkeys.

Authors:  Carole Browne; Joseph R Tobin; Mary Lou Voytko
Journal:  Brain Res       Date:  2009-01-20       Impact factor: 3.252

10.  Tibolone prevents oxidation and ameliorates cholinergic deficit induced by ozone exposure in the male rat hippocampus.

Authors:  E D Farfán-García; M C Castillo-Hernández; R Pinto-Almazán; S Rivas-Arancibia; J M Gallardo; C Guerra-Araiza
Journal:  Neurochem Res       Date:  2014-07-23       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.